Recent Progress of Tertiary Lymphoid Structure in Prognosis and Immunotherapy of Non-small Cell Lung Cancer
Lung cancer is the leading cause of cancer death, and non-small cell lung cancer (NSCLC) accounts for 85%. Immunotherapy has significantly improved the clinical prognosis of patients with NSCLC. However, because of the complexity and heterogeneousness of the tumor microenvironment, only a subset of...
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Статья |
| Язык: | zho |
| Опубликовано: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-08-01
|
| Серии: | Chinese Journal of Lung Cancer |
| Предметы: | |
| Online-ссылка: | http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.23 |